A 24-week randomized, controlled, multicenter, open-label study to - Trial 2017-001593-42
Access comprehensive clinical trial information for 2017-001593-42 through Pure Global AI's free database. This phase not specified trial is sponsored by Novartis Pharma AG and is currently status unknown. The study focuses on Chronic Obstructive Pulmonary Disease (COPD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2017-001593-42
Trial Details
EU Clinical Trials Register • 2017-001593-42
A 24-week randomized, controlled, multicenter, open-label study to
Study Focus
Sponsor & Location
Novartis Pharma AG
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
1. Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female
ICD-10 Classifications
Other chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease, unspecified
Other specified chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
Chronic obstructive pulmonary disease with acute lower respiratory infection
Data Source
EU Clinical Trials Register
2017-001593-42
Non-Device Trial